Mechanism
AT1R; neprilysin
Assets acting on this target.
- Class
- Angiotensin receptor-neprilysin inhibitor (ARNI)
- Notes
- hand ruling, audit finding #1978; OVERRIDE: the source says AT1 receptor blocker, not AT2R. A real two-target to two-target correction that the splitter read as three-to-two; source: https://clinicaltrials.gov/api/v2/studies/NCT07700875